Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking a double dose of semaglutide is not recommended and, in most situations, carries real risks that outweigh any perceived benefit. Semaglutide — the medicine in Wegovy — follows a carefully stepped schedule set by your prescriber; doubling a dose does not accelerate the process and can cause serious gastrointestinal harm. If you are wondering whether taking more will speed up your results, you are not alone in asking, but the answer from clinical guidance is clear. These are prescription-only medicines, and any change to the dose your prescriber has set should go through them, not around them.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who search this question are in one of two situations. Either they missed their weekly injection and are unsure what to do, or they feel their current dose is not working fast enough and want to take matters into their own hands. Both feelings are understandable. Weight management is rarely a smooth line, and when you are doing everything right and progress slows, the temptation to do more is real.
The clinical reality is that semaglutide's titration schedule exists precisely because the body needs time to adjust. Starting at 0.25mg and moving up in roughly four-weekly steps is not a bureaucratic formality, it is how the medicine becomes tolerable. At each level, the body's response to the GLP-1 receptor pathway settles, and side effects that would be severe at a higher starting dose become manageable. Jumping to a double dose collapses that buffer entirely.
Your prescriber sets your current dose based on your full clinical picture. Changing it unilaterally is not a shortcut, it removes the clinical oversight that makes the medicine safe. If you feel your dose should be reviewed, that conversation belongs with your prescribing team. You can read more about how the semaglutide dose schedule works and what drives each step.
Semaglutide slows gastric emptying and acts on appetite centres in the brain. At the doses in the titration schedule, most people experience some nausea, particularly after a dose increase. That side effect is predictable and, for most, short-lived. At double the intended dose, the same mechanism becomes far more intense.
Clinical reports and the medicine's SmPC are consistent on this: overdose scenarios produce prolonged nausea, repeated vomiting, severe diarrhoea, and in some cases dehydration significant enough to affect kidney function. The NHS semaglutide medicines page is explicit that if you take too much, you should contact a medical professional promptly and bring the packaging.
There is also no evidence that a higher accidental dose accelerates fat loss in any meaningful way. The appetite-suppression effect is not dose-linear in the way that assumption implies. You are more likely to spend several days unable to eat through nausea than to see any additional benefit. Worth being direct about: the risk-to-reward calculation here is not close.
For specific questions about what happens when doses are doubled in the context of Wegovy's schedule, our page on what a Wegovy double dose involves covers the clinical reasoning in detail, and if you are still weighing up whether it could ever be appropriate, you can find a thorough answer on our page covering whether you can double up on Wegovy shots, as well as the guidance on whether you can take a double dose of Wegovy which addresses that question directly.
This is a common, practical concern and one the Patient Information Leaflet addresses directly. If you have missed your weekly injection and fewer than five days have passed since it was due, you can take it as soon as you remember. If more than five days have passed, skip that dose entirely and take the next one on your usual scheduled day. Do not take two doses in the same week.
That guidance applies across the titration schedule, including at the higher doses. The full breakdown of Wegovy dose stages sets out the schedule, but the missed-dose rule is consistent at every level. Your prescriber or the PIL for your specific pen is always the definitive source, especially if you are at a higher maintenance strength or have a reason your situation might differ from the standard rule.
A question our prescribers hear regularly is whether missing one injection means progress is lost. It does not. A single missed dose has a limited impact on the medicine's overall effect; semaglutide has a long half-life, which is part of why once-weekly dosing works. The concern about losing ground is real, but the answer is to resume on schedule, not to compensate.
If you feel your current semaglutide dose is no longer working, or that you have plateaued, that is a legitimate clinical conversation. The licensed titration pathway runs from 0.25mg up through 0.5mg, 1.0mg, 1.7mg, and 2.4mg; if you are wondering whether a semaglutide 2 mg dose might be a step on your own pathway, that page explains what to expect at that level. The MHRA approved a 7.2mg maintenance dose in January 2026, which is now the highest available strength. Moving through those steps, or to a higher dose, requires prescriber assessment, evidence of how you have responded, what side effects you have experienced, and whether it is clinically appropriate to escalate.
At nume, every repeat order is clinically re-reviewed before dispatch. Dose increases go through the same process: a prescriber (a real person, not software) reviews the evidence before any escalation is approved. That is not a barrier to progress; it is how dose changes stay safe.
If you are thinking about whether a higher dose might be right for you, or whether a different treatment altogether could be a better fit, exploring the full range of licensed weight-loss options is a useful starting point. And if you are ready to talk to a prescriber about where you are in your treatment, you can check your eligibility and start a free consultation at any point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.